Standout Papers

MYC as a target for cancer treatment 2021 2026 2022 2024277
  1. MYC as a target for cancer treatment (2021)
    Michael J. Duffy, Shane O’Grady et al. Cancer Treatment Reviews

Immediate Impact

1 from Science/Nature 53 standout
Sub-graph 1 of 23

Citing Papers

Combating Antibiotic-Resistant Bacterial Infection Using Coassembled Dimeric Antimicrobial Peptide-Based Nanofibers
2025 Standout
Inflammation in cancer: therapeutic opportunities from new insights
2025 Standout
1 intermediate paper

Works of Shane O’Grady being referenced

MYC as a target for cancer treatment
2021 Standout
Polymeric prodrug combination to exploit the therapeutic potential of antimicrobial peptides against cancer cells
2016

Author Peers

Author Last Decade Papers Cites
Shane O’Grady 351 591 19 207 19 949
Simon A. Williams 337 520 189 24 958
Ignacio Dolado 323 682 7 169 20 987
Gaynor Davies 350 573 2 254 22 1.0k
Guangchun He 318 464 2 294 25 924
Peter H. Clingen 221 687 5 243 17 980
Yiyu Dong 318 708 1 199 25 1.1k
Dongkyoo Park 280 536 14 136 19 788
Wenhao Guo 233 491 2 244 31 1.0k
Danupon Nantajit 340 550 5 227 20 910
Jinah Park 255 766 12 179 32 1.0k

All Works

Loading papers...

Rankless by CCL
2026